{"contacts": [{"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Ana Konvalinka"}, {"accession": "MS:1000589", "name": "contact email", "value": "ana.konvalinka@uhn.ca"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University Health Network, Toronto, Ontario, Canada"}]}, {"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Julie Van"}, {"accession": "MS:1000589", "name": "contact email", "value": "julie.van@mail.utoronto.ca"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Toronto"}]}], "description": " 0.05). One of the validated peptides activated TLR4-dependent NF\u03baB signalling, stimulated cytokine release, and enhanced neutrophil migration in vitro. In silico analyses identified several possible proteases such hepsin, cathepsin B, and meprin A to be responsible for generating these peptides. In summary, uromodulin processing in the kidney produces bioactive peptides, which may be differentially excreted in early diabetes.", "fullDatasetLinks": [{"accession": "MS:1002873", "name": "Panorama Public dataset URI", "value": "https://panoramaweb.org/lotso19.url"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD012389"}, {"accession": "MS:1002872", "name": "Panorama Public dataset identifier", "value": "https://panoramaweb.org/lotso19.url"}], "instruments": [{"accession": "MS:1002877", "name": "Q Exactive HF-X"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "urine"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "peptidomics"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "type 1 diabetes"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "kidney disease"}], "modifications": [{"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "UNIMOD:35", "name": "Oxidation"}, {"accession": "UNIMOD:259", "name": "Label:13C(6)15N(2)"}, {"accession": "UNIMOD:267", "name": "Label:13C(6)15N(4)"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "31879271"}, {"accession": "MS:1002866", "name": "Reference", "value": "Van JAD, Clotet-Freixas S, Zhou J, Batruch I, Sun C, Glogauer M, Rampoldi L, Elia Y, Mahmud F, Sochett E, Diamandis EP, Scholey J, Konvalinka A. Peptidomic analysis of urine from youths with early type 1 diabetes reveals novel bioactivity of uromodulin peptides in vitro. Mol Cell Proteomics. 2019 Dec;"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Urinary PRM analysis of early type 1 diabetes"}